Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Exp Med. Dec 20, 2023; 13(5): 115-122
Published online Dec 20, 2023. doi: 10.5493/wjem.v13.i5.115
Table 1 Demographic and clinical characteristics of the patients, N (%)
Variable
Non-POF (n = 68)
POF (n = 34)
Univariate P
Multivariate P
Age (yr)40 ± 840 ± 90.967
Sex (M/F)56/1229/50.785
Hypertension16 (24)7 (21)0.876
Diabetes33 (49) 22 (65)0.144
Fatty liver disease39 (57)16 (47)0.679
Alcohol28 (41)15 (44)0.833
Smoking45 (66)21 (62)0.667
WBC (x109/L)12.4 (10.9, 15.9)14.9 (13.2, 17.1)0.0090.172
MPV (fL)10.42 ± 1.7611.54 ± 2.060.0120.085
RDW (%)12.5 (12.0, 13.0)14.4 (13.4, 14.9)< 0.0010.002
Amylase (U/L)124 (66, 258)239 (83, 917)0.0360.383
Calcium (mmol/L)2.35 (2.25, 2.42)2.29 (2.10, 2.95)0.064
Triglyceride (mmol/L)16.42 (11.58, 20.31)19.57 (15.23, 24.70)0.0100.101
ALT (U/L)36.0 (25.0, 47.4)35.2 (20.8, 46.6)0.412
AST (U/L)25.9 (19.1, 31.7)25.4 (17.9, 33.6)0.879
Albumin (g/L)46.1 (44.1, 48.4)44.8 (42.1, 48.3)0.078
BUN (mmol/L)4.30 (3.60, 5.18)3.85 (2.90, 5.00)0.057
Creatinine (μmol/l)60.50 (47.50, 76.55)54.90 (41.70, 71.05)0.158
C-reaction protein (mg/L)24.89 (11.14, 57.54)63.10 (23.57, 99.91)0.0080.185
BISAP1 (0, 1)2 (1, 2)< 0.0010.001
APACHE II 4 (2, 5)5 (4, 8)< 0.0010.119